CRYSVITA 10 MG Iisrael - inglise - Ministry of Health

crysvita 10 mg

medison pharma ltd - burosumab - solution for injection - burosumab 10 mg / 1 ml - burosumab - crysvita is indicated for the treatment of x-linked hypophosphatemia (xlh) in adult and paediatric patients 6 months of age and oldertumor-induced osteomalaciacrysvita is indicated for the treatment of fgf23‐related hypophosphatemia in tumor‐induced osteomalacia (tio) associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized in adult and pediatric patients 2 years of age and older.

CRYSVITA 20 MG Iisrael - inglise - Ministry of Health

crysvita 20 mg

medison pharma ltd - burosumab - solution for injection - burosumab 20 mg / 1 ml - burosumab - crysvita is indicated for the treatment of x-linked hypophosphatemia (xlh) in adult and paediatric patients 6 months of age and oldertumor-induced osteomalaciacrysvita is indicated for the treatment of fgf23‐related hypophosphatemia in tumor‐induced osteomalacia (tio) associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized in adult and pediatric patients 2 years of age and older.

CRYSVITA 30 MG Iisrael - inglise - Ministry of Health

crysvita 30 mg

medison pharma ltd - burosumab - solution for injection - burosumab 30 mg / 1 ml - burosumab - crysvita is indicated for the treatment of x-linked hypophosphatemia (xlh) in adult and paediatric patients 6 months of age and oldertumor-induced osteomalaciacrysvita is indicated for the treatment of fgf23‐related hypophosphatemia in tumor‐induced osteomalacia (tio) associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized in adult and pediatric patients 2 years of age and older.

XADAGO 100 MG Iisrael - inglise - Ministry of Health

xadago 100 mg

medison pharma ltd - safinamide as methanesulfonate - film coated tablets - safinamide as methanesulfonate 100 mg - safinamide - xadago is indicated for the treatment of adult patients with idiopathic parkinson’s disease (pd) as add-on therapy to a stable dose of levodopa (l-dopa) alone or in combination with other pd medicinal products in mid-to late-stage fluctuating patients.

XADAGO 50 MG Iisrael - inglise - Ministry of Health

xadago 50 mg

medison pharma ltd - safinamide as methanesulfonate - film coated tablets - safinamide as methanesulfonate 50 mg - safinamide - xadago is indicated for the treatment of adult patients with idiopathic parkinson’s disease (pd) as add-on therapy to a stable dose of levodopa (l-dopa) alone or in combination with other pd medicinal products in mid-to late-stage fluctuating patients.

BRUKINSA Iisrael - inglise - Ministry of Health

brukinsa

medison pharma ltd - zanubrutinib - capsules - zanubrutinib 80 mg - • brukinsa is indicated for the treatment of adult patients with mantle cell lymphoma (mcl) who have received at least one prior therapy.• brukinsa is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm).• brukinsa is indicated for the treatment of adult patients with relapsed or refractory marginal zone lymphoma (mzl) who have received at least one anti-cd20-based regimen.• brukinsa is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll) or small lymphocytic lymphoma (sll).

TAVALISSE 100 MG Iisrael - inglise - Ministry of Health

tavalisse 100 mg

medison pharma ltd - fostamatinib as disodium hexahydrate - film coated tablets - fostamatinib as disodium hexahydrate 100 mg - fostamatinib - tavalisse is indicated for the treatment of chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments.

TAVALISSE 150 MG Iisrael - inglise - Ministry of Health

tavalisse 150 mg

medison pharma ltd - fostamatinib as disodium hexahydrate - film coated tablets - fostamatinib as disodium hexahydrate 150 mg - fostamatinib - tavalisse is indicated for the treatment of chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments.

VUMERITY 231 MG Iisrael - inglise - Ministry of Health

vumerity 231 mg

medison pharma ltd - diroximel fumarate - capsules delayed release - diroximel fumarate 231 mg - vumerity is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis.

Samsung Medison V8 Diagnostic Ultrasound System Singapur - inglise - HSA (Health Sciences Authority)

samsung medison v8 diagnostic ultrasound system

quest asia technologies pte ltd - radiology / imaging - the ultrasound diagnostic system and probes are designed to obtain ultrasound images and analyze body fluids. the clinical applications include: fetal/obstetrics, abdominal, gynecology, intra- operative, pediatric, small organ, neonatal cephalic, adult cephalic, trans-rectal, trans- vaginal, muscular-skeletal (conventional, superficial), urology, cardiac adult, cardiac pediatric, thoracic, trans-esophageal (cardiac) and peripheral vessel